(Q44631148)

4 December 2017

title

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection (English)

1 reference

4 December 2017

1 reference

1 reference

1

1 reference

4 December 2017

Bolyn Hubby

2

1 reference

4 December 2017

David L Suarez

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

23 February 2007

1 reference

4 December 2017

1 reference

4 December 2017

volume

25

1 reference

4 December 2017

issue

19

1 reference

4 December 2017

page(s)

3763-3772

1 reference

Functional significance of sialidose during influenza virus multiplication

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

The significance of influenza virus neuraminidase in immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Efficacy of avian influenza neuraminidase-specific vaccines in chickens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Protection against lethal influenza with neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Alphavirus expression vectors and their use as recombinant vaccines: a minireview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Alphavirus-based expression vectors: strategies and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Development of Hemagglutinin Subtype–Specific Reference Antisera by DNA Vaccination of Chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Isolation and characterization of H3N2 influenza A virus from turkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Evolution of swine H3N2 influenza viruses in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.011

10.1016/J.VACCINE.2007.02.011

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference